Cisplatin-based concurrent chemoradiotherapy improved the survival of locoregionally advanced nasopharyngeal carcinoma after induction chemotherapy by reducing early treatment failure

Abstract Purpose The aims of this study focusing on Locoregionally advanced nasopharyngeal carcinoma (LANPC) were mainly two-fold: on the one hand, to establish a cut-off value to differentiate early and late failure based on prognosis after recurrence or metastasis; and on the other hand, to invest...

Full description

Bibliographic Details
Published in:BMC Cancer
Main Authors: Xing-Li Yang, Lu-Lu Zhang, Jia Kou, Guan-Qun Zhou, Chen-Fei Wu, Ying Sun, Li Lin
Format: Article
Language:English
Published: BMC 2022-11-01
Subjects:
Nasopharyngeal carcinoma
Chemotherapy
Cisplatin dose
Failure
Survival
Online Access:https://doi.org/10.1186/s12885-022-10237-8

Internet

https://doi.org/10.1186/s12885-022-10237-8

Similar Items